Corrigendum

Abstract

European Journal of HaematologyVolume 91, Issue 6 p. 565-565 CorrigendumFree Access Corrigendum This article corrects the following: Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression Ayako Ichikawa, Fumiko Arakawa, Junichi Kiyasu, Kensaku Sato, Hiroaki Miyoshi, Daisuke Niino, Yoshizo Kimura, Masanori Takeuchi, Maki Yoshida, Yukinao Ishibashi, Shinji Nakashima, Yasuo Sugita, Osamu Miura, Koichi Ohshima, Volume 91Issue 1European Journal of Haematology pages: 20-28 First Published online: May 13, 2013 First published: 19 November 2013 https://doi.org/10.1111/ejh.12225AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat In (1), the following error occurred. In Figure 2, under “Non MTX-LPD (n=17)”, “Withdrawal of MTX (2 cases)” should be amended to “Withdrawal of immunosuppressant (2 cases)”. The authors apologize for the error. Reference 1Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein–Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 2013;91:20–28. doi: 10.1111/ejh.12116 Wiley Online LibraryWeb of Science®Google Scholar Volume91, Issue6December 2013Pages 565-565 ReferencesRelatedInformation